The Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is an innovative platform technology offering significant patient, mobility and economic advantages. The Xoft System utilizes a proprietary miniaturized x-ray source to deliver radiation directly to the tumor site in or on the body. This technology targets cancer while minimizing exposure to surrounding healthy tissue. The Xoft System is FDA cleared and CE marked in the EU for use anywhere in the body, including treatment of early-stage breast cancer, non-melanoma skin cancer, and gynecological cancers.

Xoft’s unique 50kV stepping source combines high dose rate with low energy radiation, enabling the procedure to be completed under the supervision of a radiation oncologist in a minimally shielded setting. The mobility of the Xoft System coupled with its ability to treat multiple indications, gives clinicians and patients greater access to electronic brachytherapy as a treatment option.

Literature Library

Clinical Data



Contact Us

Sales & Services

+1 877 963 8327 toll free

©2017 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.

Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.